1.47USD
48.16 MUSD
566.77 MUSD
30.58 M
About Collegium Pharmaceutical, Inc.
Sector
CEO
Joseph J. Ciaffoni
Headquarters
Stoughton
Website
Employees (FY)
197
Founded
2002
ISIN
US19459J1043
FIGI
BBG000N7LPW4
Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. The company was founded by Michael Thomas Heffernan in April 2002 and is headquartered in Stoughton, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of COLL is 35.24 USD — it has increased by 0.28% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Collegium Pharmaceutical, Inc. stocks are traded under the ticker COLL.
Collegium Pharmaceutical, Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Collegium Pharmaceutical, Inc. has a max estimate of 41.00 USD and a min estimate of 39.00 USD.
COLL earnings for the last quarter are 1.34 USD whereas the estimation was 1.22 USD which accounts for 10.00% surprise. Estimated earnings for the next quarter are 1.38 USD. See more details about Collegium Pharmaceutical, Inc. earnings.
Collegium Pharmaceutical, Inc. revenue for the last quarter amounts to 136.71 M USD despite the estimated figure of 137.27 M USD. In the next quarter revenue is expected to reach 147.86 M USD.
Yes, you can track Collegium Pharmaceutical, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, COLL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Collegium Pharmaceutical, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 197.00 employees. See our rating of the largest employees — is Collegium Pharmaceutical, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Collegium Pharmaceutical, Inc. EBITDA is 324.46 M USD, and current EBITDA margin is 57.29%. See more stats in Collegium Pharmaceutical, Inc. financial statements.